CN111956612A - Oxytetracycline spray and preparation method thereof - Google Patents
Oxytetracycline spray and preparation method thereof Download PDFInfo
- Publication number
- CN111956612A CN111956612A CN202010819861.8A CN202010819861A CN111956612A CN 111956612 A CN111956612 A CN 111956612A CN 202010819861 A CN202010819861 A CN 202010819861A CN 111956612 A CN111956612 A CN 111956612A
- Authority
- CN
- China
- Prior art keywords
- oxytetracycline
- spray
- add
- mix
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明属于兽用医药领域,提供一种土霉素喷雾剂及其制备方法。本发明每1000g,包括主要成分20‑300g、络合剂10‑500g、有机溶剂200‑900g、保湿剂10‑100g、成膜剂10g‑200g、pH调节剂5‑100g、着色剂0.05‑50g,余量为纯化水;所述主要成分选自土霉素和盐酸土霉素的一种或两种。本发明喷出的药物分散均匀、稳定,使用安全,可多次给药,包装成本低,能够有效、方便治疗动物外伤,该制剂为外用药,喷在动物体表,无兽药残留,无休药期。The invention belongs to the field of veterinary medicine and provides an oxytetracycline spray and a preparation method thereof. Every 1000g of the present invention includes 20-300g of main components, 10-500g of complexing agent, 200-900g of organic solvent, 10-100g of moisturizing agent, 10-200g of film-forming agent, 5-100g of pH adjusting agent, and 0.05-50g of colorant , the remainder is purified water; the main component is selected from one or both of oxytetracycline and oxytetracycline hydrochloride. The medicine sprayed by the invention is evenly dispersed and stable, safe to use, can be administered multiple times, has low packaging cost, and can effectively and conveniently treat animal trauma. drug period.
Description
技术领域technical field
本发明属于兽用医药领域,具体涉及一种土霉素喷雾剂及其制备方法。The invention belongs to the field of veterinary medicine, in particular to an oxytetracycline spray and a preparation method thereof.
背景技术Background technique
土霉素属于四环素类广谱抗生素,对葡萄球菌、溶血性链球菌、炭疽杆菌、破伤风梭菌和梭状芽胞杆菌等革兰氏阳性菌作用较强,对大肠埃希菌、沙门氏菌、布鲁氏菌和巴氏杆菌等革兰氏阴性菌较敏感。本品对立克次体、衣原体、支原体、螺旋体、放线菌和某些原虫也有抑制作用。Oxytetracycline belongs to tetracycline broad-spectrum antibiotics, and has strong effect on gram-positive bacteria such as Staphylococcus, hemolytic streptococcus, Bacillus anthracis, Clostridium tetani and Clostridium spp. Gram-negative bacteria such as L. brucei and Pasteurella are more susceptible. This product also has inhibitory effects on rickettsia, chlamydia, mycoplasma, spirochetes, actinomycetes and some protozoa.
动物外伤,特别是腐蹄病,最为常见,因养殖环境条件差往往引起细菌感染,经久不愈,土霉素为广谱抗生素,对动物外伤有很好的治疗。在兽医上土霉素及盐酸土霉素广泛用于口服和注射,但目前还没有土霉素喷雾剂及其制备方法。Animal trauma, especially hoof rot, is the most common. Bacterial infection is often caused by poor breeding environment, which will not heal for a long time. Oxytetracycline is a broad-spectrum antibiotic, which has a good treatment for animal trauma. In veterinary medicine, oxytetracycline and oxytetracycline hydrochloride are widely used for oral administration and injection, but there is no oxytetracycline spray and its preparation method.
发明内容SUMMARY OF THE INVENTION
本发明为了解决上述现有技术中存在的问题,提供了一种土霉素喷雾剂及其制备方法,喷出的药物分散均匀、稳定,使用安全,可多次给药,包装成本低,能够有效、方便治疗动物外伤,该制剂为外用药,喷在动物体表,无兽药残留,无休药期。In order to solve the above-mentioned problems in the prior art, the present invention provides an oxytetracycline spray and a preparation method thereof. The sprayed medicine is uniform and stable, safe to use, can be administered multiple times, has low packaging cost, and can It is effective and convenient for the treatment of animal trauma. The preparation is an external drug, sprayed on the surface of the animal body, and has no veterinary drug residue and no drug withdrawal period.
本发明采用的具体技术方案是:一种土霉素喷雾剂,关键是,每1000g,包括主要成分20-300g、络合剂10-500g、有机溶剂200-900g、保湿剂10-100g、成膜剂10g-200g、pH调节剂5-100g、着色剂0.05-50g,余量为纯化水;The specific technical scheme adopted in the present invention is: an oxytetracycline spray, the key is that every 1000g includes 20-300g of main components, 10-500g of complexing agent, 200-900g of organic solvent, 10-100g of moisturizing agent, 10g-200g of film agent, 5-100g of pH adjuster, 0.05-50g of colorant, and the balance is purified water;
所述主要成分选自土霉素和盐酸土霉素的一种或两种。The main component is selected from one or both of oxytetracycline and oxytetracycline hydrochloride.
优选地,所述有机溶剂选自甲醇、乙醇、异丙醇、二甲基甲酰胺、二甲基乙酰胺、2-吡咯烷酮和甲基吡咯烷酮的一种或至少两种。Preferably, the organic solvent is selected from one or at least two of methanol, ethanol, isopropanol, dimethylformamide, dimethylacetamide, 2-pyrrolidone and methylpyrrolidone.
优选地,所述络合剂选自氧化镁、氯化镁、氢氧化镁、碳酸镁中的一种或至少两种。Preferably, the complexing agent is selected from one or at least two of magnesium oxide, magnesium chloride, magnesium hydroxide, and magnesium carbonate.
优选地,所述保湿剂选自丙二醇、甘油、聚乙二醇中的一种或至少两种。Preferably, the humectant is selected from one or at least two of propylene glycol, glycerin, and polyethylene glycol.
优选地,所述的成膜剂为聚维酮K12、聚维酮K17和聚维酮K30的一种或至少两种。Preferably, the film-forming agent is one or at least two of povidone K12, povidone K17 and povidone K30.
优选地,所述的pH调节剂为盐酸、乳酸、氢氧化钠、乙醇胺、二乙醇胺、三乙醇胺和柠檬酸钠中的一种或至少两种。Preferably, the pH adjusting agent is one or at least two selected from hydrochloric acid, lactic acid, sodium hydroxide, ethanolamine, diethanolamine, triethanolamine and sodium citrate.
优选地,所述的着色剂为亮蓝、专利蓝、蓝色、胭脂色、甲紫和葡萄紫中的一种或至少两种。Preferably, the colorant is one or at least two selected from brilliant blue, patent blue, blue, carmine, nail violet and grape violet.
一种土霉素喷雾剂的制备方法,关键是,包括以下步骤:A kind of preparation method of oxytetracycline spray, the key is, comprises the following steps:
A、将络合剂加入70g~120g纯化水中混匀得到原液;A. The complexing agent is added into 70g~120g purified water and mixed to obtain a stock solution;
B、在原液中加入有机溶剂、保湿剂混匀;B. Add organic solvent and humectant to the original solution and mix well;
C、在步骤B得到的溶液中加入成膜剂混匀至溶解;C, in the solution obtained in step B, add film-forming agent and mix to dissolve;
D、在步骤C得到的溶液中加入盐酸土霉素或土霉素混匀至溶解D, in the solution obtained in step C, add oxytetracycline hydrochloride or oxytetracycline and mix until dissolved
E、在步骤D得到的溶液中加入PH调节剂调节pH为8.0~9.0;E, in the solution that step D obtains, add pH regulator to adjust pH to be 8.0~9.0;
F、在步骤E得到的溶液中加入着色剂,加入纯化水至1000g,混匀至溶解,过滤,灌封至喷雾剂专用瓶中,得到所述土霉素喷雾剂。F. Add a colorant to the solution obtained in step E, add purified water to 1000 g, mix to dissolve, filter, and fill in a special bottle for spray to obtain the oxytetracycline spray.
优选地,所述的喷雾剂专用瓶中为带有喷雾装置的塑料瓶或带有喷雾装置的玻璃瓶。Preferably, the dedicated spray bottle is a plastic bottle with a spray device or a glass bottle with a spray device.
本发明的有益效果是:本发明制得的土霉素喷雾剂喷出的药物分散均匀、稳定,使用安全,可多次给药,包装成本低,用于治疗由多种细菌引起的动物外伤,缩短了疼痛和康复的时间,减轻了患病动物的痛苦。The beneficial effects of the invention are as follows: the oxytetracycline spray prepared by the invention has the advantages of uniform dispersion and stability, safe use, multiple administration, low packaging cost, and is used for treating animal trauma caused by various bacteria , shortens the time of pain and recovery, and relieves the suffering of sick animals.
具体实施方式Detailed ways
下面结合具体实施例对本发明作进一步说明:Below in conjunction with specific embodiment, the present invention will be further described:
实施例1Example 1
处方prescription
过程process
A、将氯化镁加入70g~120g纯化水中溶解得到原液;A, adding magnesium chloride to 70g~120g purified water and dissolving to obtain stock solution;
B、在原液中加入异丙醇、丙二醇混匀;B. Add isopropanol and propylene glycol to the stock solution and mix;
C、再加入聚维酮K17混匀至溶解;C, then add povidone K17 and mix to dissolve;
D、再加入盐酸土霉素混匀至溶解;D. Add oxytetracycline hydrochloride and mix until dissolved;
E、再加入乙醇胺调节pH为8.0~9.0;E, then add ethanolamine to adjust pH to 8.0~9.0;
F、再加入亮蓝,加入纯化水至1000g,混匀至溶解,过滤,取150g灌封至喷雾剂专用瓶中,得到所述土霉素喷雾剂。F. Add bright blue again, add purified water to 1000g, mix to dissolve, filter, take 150g and fill it into a special bottle for spray to obtain the oxytetracycline spray.
实施例2Example 2
处方prescription
过程process
A、将氯化镁加入70g~120g纯化水中溶解得到原液;A, adding magnesium chloride to 70g~120g purified water and dissolving to obtain stock solution;
B、在原液中加入乙醇、丙二醇混匀;B. Add ethanol and propylene glycol to the stock solution and mix;
C、再加入聚维酮K17混匀至溶解;C, then add povidone K17 and mix to dissolve;
D、再加入盐酸土霉素混匀至溶解;D. Add oxytetracycline hydrochloride and mix until dissolved;
E、再加入乙醇胺调节pH为8.0~9.0;E, then add ethanolamine to adjust pH to 8.0~9.0;
F、再加入亮蓝,加入纯化水至1000g,混匀至溶解,过滤,取150g灌封至喷雾剂专用瓶中,得到所述土霉素喷雾剂。F. Add bright blue again, add purified water to 1000g, mix to dissolve, filter, take 150g and fill it into a special bottle for spray to obtain the oxytetracycline spray.
实施例3Example 3
处方prescription
过程process
A、将氯化镁加入70g~120g纯化水中溶解得到原液;A, adding magnesium chloride to 70g~120g purified water and dissolving to obtain stock solution;
B、在原液中加入二甲基乙酰胺、丙二醇混匀;B. Add dimethylacetamide and propylene glycol to the stock solution and mix;
C、再加入聚维酮K12混匀至溶解;C, then add povidone K12 and mix to dissolve;
D、再加入土霉素混匀至溶解;D. Add oxytetracycline and mix until dissolved;
E、再加入乙醇胺调节pH为8.0~9.0;E, then add ethanolamine to adjust pH to 8.0~9.0;
F、再加入亮蓝,加入纯化水至1000g,混匀至溶解,过滤,取150g灌封至喷雾剂专用瓶中,得到所述土霉素喷雾剂。F. Add bright blue again, add purified water to 1000g, mix to dissolve, filter, take 150g and fill it into a special bottle for spray to obtain the oxytetracycline spray.
实施例4Example 4
处方prescription
过程process
A、将氯化镁加入70g~120g纯化水中溶解得到原液;A, adding magnesium chloride to 70g~120g purified water and dissolving to obtain stock solution;
B、在原液中加入甲基吡咯烷酮、丙二醇混匀;B. Add methylpyrrolidone and propylene glycol to the stock solution and mix;
C、再加入聚维酮K30混匀至溶解;C, then add Povidone K30 and mix to dissolve;
D、再加入土霉素混匀至溶解;D. Add oxytetracycline and mix until dissolved;
E、再加入乙醇胺调节pH为8.0~9.0;E, then add ethanolamine to adjust pH to 8.0~9.0;
F、再加入亮蓝,加入纯化水至1000g,混匀至溶解,过滤,取150g灌封至喷雾剂专用瓶中,得到所述土霉素喷雾剂。F. Add bright blue again, add purified water to 1000g, mix to dissolve, filter, take 150g and fill it into a special bottle for spray to obtain the oxytetracycline spray.
试验例1Test Example 1
将实施例3制备的土霉素喷雾剂分为3批,进行稳定性试验观察,包括影响因素试验(高温、光照)、加速试验(温度40±2℃,RH75±5%)6个月和长期试验(25±2℃,RH60±10%)24个月,试验条件、考察时间及考察项目如表1所示,试验结果见表1-4:The oxytetracycline spray prepared in Example 3 was divided into 3 batches, and the stability test was observed, including the influence factor test (high temperature, light), accelerated test (temperature 40±2°C, RH75±5%) for 6 months and Long-term test (25±2℃, RH60±10%) for 24 months, test conditions, inspection time and inspection items are shown in Table 1, and test results are shown in Table 1-4:
表1:土霉素喷雾剂稳定性试验内容及考察项目Table 1: Contents and investigation items of stability test of oxytetracycline spray
表2影响因素试验结果Table 2 Test results of influencing factors
表3加速试验结果Table 3 Accelerated test results
表4长期试验结果Table 4 Long-term test results
由表格可知,本发明制得的土霉素喷雾剂稳定性好,保质期长,能在较高的温度下保存,见光不易分解,耐光照。As can be seen from the table, the oxytetracycline spray prepared by the present invention has good stability, long shelf life, can be stored at a relatively high temperature, is not easily decomposed when exposed to light, and is resistant to light.
试验例2Test Example 2
按照实施例3制备的土霉素喷雾剂对牛、羊、猪腐蹄病效果观察,选择:土霉素喷雾剂(实施例3制备的批号为20190401);10%硫酸铜溶液+涂擦消炎膏(传统疗法);碘富(双链季铵盐络合碘、镇痛新)对患病动物用药。Observation of the effect of the oxytetracycline spray prepared in Example 3 on cattle, sheep, and pig foot rot, selection: oxytetracycline spray (the batch number prepared in Example 3 is 20190401); 10% copper sulfate solution + rubbing anti-inflammatory Ointment (traditional therapy); iodine-rich (double-chain quaternary ammonium salt complexed with iodine, analgesic new) are administered to sick animals.
试验方法:选择正常饲养过程中出现典型腐蹄病的牛60头,分为I、II、III、IV组,每组15头;羊80头,分为I、II、III、IV组,每组20头,猪120头,分为I、II、III、IV组,每组30头,给药方式为外用喷射,具体试验分组及给药情况见表5Test method: Select 60 cattle with typical hoof rot disease in the normal feeding process and divide them into I, II, III, IV groups, 15 heads in each group; 80 sheep, divided into I, II, III, IV groups, each There were 20 pigs in the group and 120 pigs, divided into I, II, III, IV groups, 30 pigs in each group, and the administration method was external spray.
表5试验分组及给药情况Table 5 Test grouping and administration
临床疗效判断标准:Criteria for judging clinical efficacy:
治愈:用药3天后试验动物食欲、体温、精神状态恢复正常,站立时病蹄完全着地,正常保持负重状态,无痛感,蹄趾外皮肤正常,无糜烂、肿胀特征,蹄趾间腐肉增生现象完全消失,停药一周内不复发。Cure: After 3 days of medication, the appetite, body temperature and mental state of the test animals returned to normal, the diseased hoof completely touched the ground when standing, the normal weight-bearing state was maintained, there was no pain, the outer skin of the hoof and toes was normal, there was no erosion or swelling, and the phenomenon of carrion between the hoof and toes was complete. Disappeared, no recurrence within a week of drug withdrawal.
有效:用药3天后试验动物食欲、体温、精神状态好转,站立时病蹄可以着地,基本保持负重状态,稍有痛感,蹄趾外皮肤明显好转,糜烂、肿胀未完全消失,蹄趾间腐肉增生现象明显好转,在停药观察期内症状不再加重。Effective: After 3 days of medication, the appetite, body temperature and mental state of the test animals improved, the diseased hoof could land on the ground when standing, and the weight-bearing state was basically maintained, with a slight pain, the skin outside the hoof and toes was obviously improved, the erosion and swelling did not completely disappear, and the slough between the hoof and toes was proliferated. The phenomenon improved significantly, and the symptoms no longer aggravated during the observation period of drug withdrawal.
无效:用药3天后试验动物食欲、体温、精神状态无改善甚至继续恶化,或在停药观察期内复发。Ineffective: The appetite, body temperature and mental state of the test animals did not improve or even continued to deteriorate after 3 days of treatment, or recurred during the observation period of drug withdrawal.
表6土霉素喷雾剂对牛腐蹄病的治疗效果Table 6 The therapeutic effect of oxytetracycline spray on cattle foot rot
表7土霉素喷雾剂对羊腐蹄病的治疗效果Table 7 The therapeutic effect of oxytetracycline spray on sheep foot rot
表8土霉素喷雾剂对猪腐蹄病的治疗效果Table 8 The therapeutic effect of oxytetracycline spray on pig foot rot
从表6、7、8可知,土霉素喷雾剂可明显缓解患病动物的各种临床症状,提高治疗效果,优于10%硫酸铜溶液+涂擦消炎膏(传统疗法)、碘富(双链季铵盐络合碘、镇痛新),说明土霉素喷雾剂可以有效治疗患病动物的外伤,尤其是对腐蹄病起到一定的治疗作用,给药方式为外用喷雾,使用前摇动,喷数次直到病变完全被覆盖,使用安全,可多次给药,处理过的患畜在返回牧场前应在干燥的地面上站立一小时。As can be seen from Tables 6, 7 and 8, oxytetracycline spray can obviously relieve various clinical symptoms of sick animals and improve the therapeutic effect, which is better than 10% copper sulfate solution + Tumo anti-inflammatory cream (traditional therapy), iodine rich ( Double-chain quaternary ammonium salt complexed with iodine, analgesic new), indicating that oxytetracycline spray can effectively treat the trauma of sick animals, especially to play a certain therapeutic effect on foot rot. Shake and spray several times until the lesions are completely covered. It is safe to use and can be administered multiple times. Treated animals should stand on dry ground for one hour before returning to pasture.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010819861.8A CN111956612A (en) | 2020-08-14 | 2020-08-14 | Oxytetracycline spray and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010819861.8A CN111956612A (en) | 2020-08-14 | 2020-08-14 | Oxytetracycline spray and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111956612A true CN111956612A (en) | 2020-11-20 |
Family
ID=73387716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010819861.8A Pending CN111956612A (en) | 2020-08-14 | 2020-08-14 | Oxytetracycline spray and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111956612A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117695225A (en) * | 2023-12-26 | 2024-03-15 | 石家庄石牧药业有限公司 | Aureomycin spray and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB835603A (en) * | 1956-05-29 | 1960-05-25 | Pfizer | Improvements in or relating to oxytetracycline salt containing compositions |
| CN102614298A (en) * | 2012-04-26 | 2012-08-01 | 肖连元 | Scalding spray and preparation method thereof |
| CN104352506A (en) * | 2014-10-13 | 2015-02-18 | 四川维尔康动物药业有限公司 | Long-acting oxytetracycline injection for veterinary use and preparation technology thereof |
| US20160287614A1 (en) * | 2013-11-20 | 2016-10-06 | Lupin Limited | Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic |
| CN108653200A (en) * | 2017-03-27 | 2018-10-16 | 辽宁天鹏生物科技有限公司 | A kind of long-acting occrycetin injection and preparation method thereof |
-
2020
- 2020-08-14 CN CN202010819861.8A patent/CN111956612A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB835603A (en) * | 1956-05-29 | 1960-05-25 | Pfizer | Improvements in or relating to oxytetracycline salt containing compositions |
| CN102614298A (en) * | 2012-04-26 | 2012-08-01 | 肖连元 | Scalding spray and preparation method thereof |
| US20160287614A1 (en) * | 2013-11-20 | 2016-10-06 | Lupin Limited | Stable Pharmaceutical Formulation(s) of Tetracycline Antibiotic |
| CN104352506A (en) * | 2014-10-13 | 2015-02-18 | 四川维尔康动物药业有限公司 | Long-acting oxytetracycline injection for veterinary use and preparation technology thereof |
| CN108653200A (en) * | 2017-03-27 | 2018-10-16 | 辽宁天鹏生物科技有限公司 | A kind of long-acting occrycetin injection and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| M. HOLZHAUER等: "Comparing the curative efficacy of topical treatment with thiamphenicol and oxytetracycline on digital dermatitis lesions in dairy cattle", 《VETERINARY RECORD》, 12 May 2017 (2017-05-12), pages 1 - 4 * |
| 国家药品监督管理局执业药师资格认证中心组织编写: "《药学专业知识 一》", 31 March 2020, 中国医药科技出版社, pages: 274 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117695225A (en) * | 2023-12-26 | 2024-03-15 | 石家庄石牧药业有限公司 | Aureomycin spray and preparation method thereof |
| CN117695225B (en) * | 2023-12-26 | 2024-07-26 | 石家庄石牧药业有限公司 | Aureomycin spray and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102188422B (en) | Compound florfenicol injection and preparation method and application thereof | |
| Gisbert et al. | Two-week, high-dose proton pump inhibitor, moxifloxacin triple Helicobacter pylori therapy after failure of standard triple or non-bismuth quadruple treatments | |
| CN104323987B (en) | Mequindox injection and preparation method thereof | |
| EP1462101B1 (en) | Drinkable preparation comprising ketoprofen and use thereof in the simultaneous treatment of a group of animals of respiratory diseases | |
| CN102228462B (en) | Method for preparing veterinary oxytetracycline-artemisinin injection and clinical application of veterinary oxytetracycline-artemisinin injection | |
| CN111956612A (en) | Oxytetracycline spray and preparation method thereof | |
| CN112022809A (en) | A kind of oxytetracycline aerosol and preparation method thereof | |
| CN104586777B (en) | Ceftiofur hydrochloride powder injection and its preparation method and application | |
| CN115381771A (en) | Tylosin injection and preparation method thereof | |
| CN102614294B (en) | Compound amoxicillin suspension injection and preparation method thereof | |
| CN102755337B (en) | Compound florfenicol injection and preparation method thereof | |
| CN100534433C (en) | Ceftiofur-containing powder injection for beast | |
| CN101829129B (en) | Veterinary compound gentamycin sulfate injection and preparation method thereof | |
| CN103126982A (en) | Novel veterinary medicament meglumine enrofloxacin injection and preparation method thereof | |
| CN100536843C (en) | Pharmaceutical composition for injection containing faropenem | |
| CN105902499B (en) | Enrofloxacin soluble powder and preparation method thereof | |
| CN104856977A (en) | Externally-used film coating agent for treating fungal infection type dermatosis attacking cattle and sheep | |
| CN111568864B (en) | Colistin sulfate soluble powder capable of improving solubility and preparation method and application thereof | |
| CN101912405A (en) | A kind of pharmaceutical composition for treating bovine endometritis | |
| CN115645390A (en) | Preparation of valnemulin organic acid salt veterinary drug and application of valnemulin organic acid salt veterinary drug in preparation of drugs for treating poultry air sacculitis and pig pleuropneumonia | |
| KR20120099676A (en) | Pharmaceutical compositions | |
| CN101375859A (en) | Compound composite medicament for preventing and treating iron-deficiency anemia and secondary infection of young stock | |
| CN102743395B (en) | Compound ofloxacin injecta and preparation method thereof | |
| CN100515425C (en) | A pharmaceutical composition for preventing and treating respiratory tract and digestive tract diseases of livestock and poultry | |
| RU2799015C1 (en) | Method of local treatment of hoof diseases in cattle based on a combination of active ingredients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201120 |